THE INNOVATIVE MEDICINES INITIATIVE

The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.

IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.

IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.

EU Logoefpia Logo

 

IMI Stakeholder Forum 2013

Presentations from the IMI Stakeholder Forum are now available online

  • Spotlight on IMI's brain projects
  • IMI in the European Research Area
  • Keynote speech by Nobel Laureate Rolf Zinkernagel

ONGOING PROJECTS

  • Action on autism

    EU-AIMS is developing tools that will help us to boost our understanding of autism spectrum disorders, paving the way for new treatments

    ... more
  • Diabetes treatment gets personal

    DIRECT is identifying different subtypes of type 2 diabetes to determine the most appropriate treatments for them

    ... more
  • Get on-course!

    EMTRAIN officially launches on-course - with over 4 200 courses, it's Europe's most comprehensive biomedical R&D postgrad course portal

    ... more
  • Innovation in action

    IMI supports 40 projects with a combined budget of €1.2 billion covering drug safety & efficacy, knowledge management, and education &... more

  • Liver-friendly drugs

    MIP-DILI is developing tests to help detect liver toxicity problems early in development, saving many patients from the trauma of liver failure

    ... more
  • Patient power!

    EUPATI is developing educational resources that will empower patients to engage more effectively in the drug research and development process

    ... more
  • Taking on TB

    PreDiCT-TB is speeding up the search for new, more effective combinations of treatments to tackle the deadly disease tuberculosis (TB)

    ... more
  • Towards safer drugs

    ABIRISK is boosting the safety of biopharmaceuticals, novel drugs that have already proven effective at treating certain serious conditions.

    ... more
  • Vaccine safety

    BIOVACSAFE is developing cutting edge tools to speed up and improve the testing and monitoring of vaccine safety

    ... more
All projects

WATCH THE IMI EDUCATION & TRAINING VIDEO

Four of IMI's Education & Training projects have put together a short film presenting their work. Whether you're a student or a course provider, this video will tell you how IMI's projects can help you.

more

IMI NEWSFLASH IMI News Flash

 
  • 22/05/2013 : RT @EFPIA: "You can take a needle biopsy of tumour, but the brain is much harder to access" - from the EFPIA blog #Brainmonth http://t.co/d
  • 22/05/2013 : RT @BioCentury: EC, pharma make biggest PPP in life sciences, @EU_Commission Draghia. @IMI_JU. @EFPIA. #BioCenturyTV Watch at http://t.co/z
  • 22/05/2013 : IMI press release – Pharma-Cog & EMIF-AD projects bring #Alzheimer’s treatments closer to reality http://t.co/EYr3Ik6qu1 #brainmonth

Follow us on Twitter